IBDEI0FM ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20950,2)
 ;;=^295211
 ;;^UTILITY(U,$J,358.3,20951,0)
 ;;=V10.12^^132^1245^33
 ;;^UTILITY(U,$J,358.3,20951,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20951,1,1,0)
 ;;=1^V10.12
 ;;^UTILITY(U,$J,358.3,20951,1,8,0)
 ;;=8^Hx-Tracheal Malignancy
 ;;^UTILITY(U,$J,358.3,20951,2)
 ;;=^295212
 ;;^UTILITY(U,$J,358.3,20952,0)
 ;;=V10.21^^132^1245^21
 ;;^UTILITY(U,$J,358.3,20952,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20952,1,1,0)
 ;;=1^V10.21
 ;;^UTILITY(U,$J,358.3,20952,1,8,0)
 ;;=8^Hx-Laryngeal Malignancy
 ;;^UTILITY(U,$J,358.3,20952,2)
 ;;=^295214
 ;;^UTILITY(U,$J,358.3,20953,0)
 ;;=V10.29^^132^1245^20
 ;;^UTILITY(U,$J,358.3,20953,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20953,1,1,0)
 ;;=1^V10.29
 ;;^UTILITY(U,$J,358.3,20953,1,8,0)
 ;;=8^Hx-Intrathoracic Mal Nec
 ;;^UTILITY(U,$J,358.3,20953,2)
 ;;=^295216
 ;;^UTILITY(U,$J,358.3,20954,0)
 ;;=V10.87^^132^1245^12
 ;;^UTILITY(U,$J,358.3,20954,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20954,1,1,0)
 ;;=1^V10.87
 ;;^UTILITY(U,$J,358.3,20954,1,8,0)
 ;;=8^Hx Of Thyroid Malignancy
 ;;^UTILITY(U,$J,358.3,20954,2)
 ;;=^295245
 ;;^UTILITY(U,$J,358.3,20955,0)
 ;;=V10.51^^132^1245^1
 ;;^UTILITY(U,$J,358.3,20955,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20955,1,1,0)
 ;;=1^V10.51
 ;;^UTILITY(U,$J,358.3,20955,1,8,0)
 ;;=8^Hx Of Bladder Malignancy
 ;;^UTILITY(U,$J,358.3,20955,2)
 ;;=^295228
 ;;^UTILITY(U,$J,358.3,20956,0)
 ;;=V10.52^^132^1245^9
 ;;^UTILITY(U,$J,358.3,20956,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20956,1,1,0)
 ;;=1^V10.52
 ;;^UTILITY(U,$J,358.3,20956,1,8,0)
 ;;=8^Hx Of Kidney Malignancy
 ;;^UTILITY(U,$J,358.3,20956,2)
 ;;=^295229
 ;;^UTILITY(U,$J,358.3,20957,0)
 ;;=V10.46^^132^1245^29
 ;;^UTILITY(U,$J,358.3,20957,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20957,1,1,0)
 ;;=1^V10.46
 ;;^UTILITY(U,$J,358.3,20957,1,8,0)
 ;;=8^Hx-Prostatic Malignancy
 ;;^UTILITY(U,$J,358.3,20957,2)
 ;;=^295224
 ;;^UTILITY(U,$J,358.3,20958,0)
 ;;=V10.47^^132^1245^32
 ;;^UTILITY(U,$J,358.3,20958,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20958,1,1,0)
 ;;=1^V10.47
 ;;^UTILITY(U,$J,358.3,20958,1,8,0)
 ;;=8^Hx-Testicular Malignancy
 ;;^UTILITY(U,$J,358.3,20958,2)
 ;;=^295225
 ;;^UTILITY(U,$J,358.3,20959,0)
 ;;=V10.49^^132^1245^23
 ;;^UTILITY(U,$J,358.3,20959,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20959,1,1,0)
 ;;=1^V10.49
 ;;^UTILITY(U,$J,358.3,20959,1,8,0)
 ;;=8^Hx-Male Genit Malig Nec
 ;;^UTILITY(U,$J,358.3,20959,2)
 ;;=^295226
 ;;^UTILITY(U,$J,358.3,20960,0)
 ;;=V10.45^^132^1245^24
 ;;^UTILITY(U,$J,358.3,20960,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20960,1,1,0)
 ;;=1^V10.45
 ;;^UTILITY(U,$J,358.3,20960,1,8,0)
 ;;=8^Hx-Male Genit Malig Nos
 ;;^UTILITY(U,$J,358.3,20960,2)
 ;;=^295223
 ;;^UTILITY(U,$J,358.3,20961,0)
 ;;=V10.3^^132^1245^4
 ;;^UTILITY(U,$J,358.3,20961,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20961,1,1,0)
 ;;=1^V10.3
 ;;^UTILITY(U,$J,358.3,20961,1,8,0)
 ;;=8^Hx Of Breast Malignancy
 ;;^UTILITY(U,$J,358.3,20961,2)
 ;;=^295217
 ;;^UTILITY(U,$J,358.3,20962,0)
 ;;=V10.41^^132^1245^15
 ;;^UTILITY(U,$J,358.3,20962,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20962,1,1,0)
 ;;=1^V10.41
 ;;^UTILITY(U,$J,358.3,20962,1,8,0)
 ;;=8^Hx-Cervical Malignancy
 ;;^UTILITY(U,$J,358.3,20962,2)
 ;;=^295219
 ;;^UTILITY(U,$J,358.3,20963,0)
 ;;=V10.42^^132^1245^34
 ;;^UTILITY(U,$J,358.3,20963,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20963,1,1,0)
 ;;=1^V10.42
 ;;^UTILITY(U,$J,358.3,20963,1,8,0)
 ;;=8^Hx-Uterus Malignancy Nec
 ;;^UTILITY(U,$J,358.3,20963,2)
 ;;=^295220
 ;;^UTILITY(U,$J,358.3,20964,0)
 ;;=V10.43^^132^1245^11
 ;;^UTILITY(U,$J,358.3,20964,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20964,1,1,0)
 ;;=1^V10.43
 ;;^UTILITY(U,$J,358.3,20964,1,8,0)
 ;;=8^Hx Of Ovarian Malignancy
 ;;^UTILITY(U,$J,358.3,20964,2)
 ;;=^295221
 ;;^UTILITY(U,$J,358.3,20965,0)
 ;;=V10.44^^132^1245^18
 ;;^UTILITY(U,$J,358.3,20965,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20965,1,1,0)
 ;;=1^V10.44
 ;;^UTILITY(U,$J,358.3,20965,1,8,0)
 ;;=8^Hx-Female Genit Malg Nec
 ;;^UTILITY(U,$J,358.3,20965,2)
 ;;=^295222
 ;;^UTILITY(U,$J,358.3,20966,0)
 ;;=V10.81^^132^1245^2
 ;;^UTILITY(U,$J,358.3,20966,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20966,1,1,0)
 ;;=1^V10.81
 ;;^UTILITY(U,$J,358.3,20966,1,8,0)
 ;;=8^Hx Of Bone Malignancy
 ;;^UTILITY(U,$J,358.3,20966,2)
 ;;=^295239
 ;;^UTILITY(U,$J,358.3,20967,0)
 ;;=V10.82^^132^1245^25
 ;;^UTILITY(U,$J,358.3,20967,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20967,1,1,0)
 ;;=1^V10.82
 ;;^UTILITY(U,$J,358.3,20967,1,8,0)
 ;;=8^Hx-Malig Skin Melanoma
 ;;^UTILITY(U,$J,358.3,20967,2)
 ;;=^295240
 ;;^UTILITY(U,$J,358.3,20968,0)
 ;;=V10.83^^132^1245^31
 ;;^UTILITY(U,$J,358.3,20968,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20968,1,1,0)
 ;;=1^V10.83
 ;;^UTILITY(U,$J,358.3,20968,1,8,0)
 ;;=8^Hx-Skin Malignancy Nec
 ;;^UTILITY(U,$J,358.3,20968,2)
 ;;=^295241
 ;;^UTILITY(U,$J,358.3,20969,0)
 ;;=V10.84^^132^1245^6
 ;;^UTILITY(U,$J,358.3,20969,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20969,1,1,0)
 ;;=1^V10.84
 ;;^UTILITY(U,$J,358.3,20969,1,8,0)
 ;;=8^Hx Of Eye Malignancy
 ;;^UTILITY(U,$J,358.3,20969,2)
 ;;=^295242
 ;;^UTILITY(U,$J,358.3,20970,0)
 ;;=V10.85^^132^1245^3
 ;;^UTILITY(U,$J,358.3,20970,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20970,1,1,0)
 ;;=1^V10.85
 ;;^UTILITY(U,$J,358.3,20970,1,8,0)
 ;;=8^Hx Of Brain Malignancy
 ;;^UTILITY(U,$J,358.3,20970,2)
 ;;=^295243
 ;;^UTILITY(U,$J,358.3,20971,0)
 ;;=V10.86^^132^1245^26
 ;;^UTILITY(U,$J,358.3,20971,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20971,1,1,0)
 ;;=1^V10.86
 ;;^UTILITY(U,$J,358.3,20971,1,8,0)
 ;;=8^Hx-Malign Nerve Syst Nec
 ;;^UTILITY(U,$J,358.3,20971,2)
 ;;=^295244
 ;;^UTILITY(U,$J,358.3,20972,0)
 ;;=V10.88^^132^1245^16
 ;;^UTILITY(U,$J,358.3,20972,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20972,1,1,0)
 ;;=1^V10.88
 ;;^UTILITY(U,$J,358.3,20972,1,8,0)
 ;;=8^Hx-Endocrine Malign Nec
 ;;^UTILITY(U,$J,358.3,20972,2)
 ;;=^295246
 ;;^UTILITY(U,$J,358.3,20973,0)
 ;;=238.0^^132^1246^1
 ;;^UTILITY(U,$J,358.3,20973,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20973,1,1,0)
 ;;=1^238.0
 ;;^UTILITY(U,$J,358.3,20973,1,8,0)
 ;;=8^Bone and Articular Cartilage
 ;;^UTILITY(U,$J,358.3,20973,2)
 ;;=^81953
 ;;^UTILITY(U,$J,358.3,20974,0)
 ;;=238.1^^132^1246^3
 ;;^UTILITY(U,$J,358.3,20974,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20974,1,1,0)
 ;;=1^238.1
 ;;^UTILITY(U,$J,358.3,20974,1,8,0)
 ;;=8^Connective and Oth Soft Tissue
 ;;^UTILITY(U,$J,358.3,20974,2)
 ;;=^267776
 ;;^UTILITY(U,$J,358.3,20975,0)
 ;;=238.2^^132^1246^17
 ;;^UTILITY(U,$J,358.3,20975,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20975,1,1,0)
 ;;=1^238.2
 ;;^UTILITY(U,$J,358.3,20975,1,8,0)
 ;;=8^Skin
 ;;^UTILITY(U,$J,358.3,20975,2)
 ;;=^267777
 ;;^UTILITY(U,$J,358.3,20976,0)
 ;;=238.3^^132^1246^2
 ;;^UTILITY(U,$J,358.3,20976,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20976,1,1,0)
 ;;=1^238.3
 ;;^UTILITY(U,$J,358.3,20976,1,8,0)
 ;;=8^Breast
 ;;^UTILITY(U,$J,358.3,20976,2)
 ;;=^81956
 ;;^UTILITY(U,$J,358.3,20977,0)
 ;;=238.4^^132^1246^15
 ;;^UTILITY(U,$J,358.3,20977,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20977,1,1,0)
 ;;=1^238.4
 ;;^UTILITY(U,$J,358.3,20977,1,8,0)
 ;;=8^Polycythemia Vera
 ;;^UTILITY(U,$J,358.3,20977,2)
 ;;=^304816
 ;;^UTILITY(U,$J,358.3,20978,0)
 ;;=238.5^^132^1246^6
 ;;^UTILITY(U,$J,358.3,20978,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20978,1,1,0)
 ;;=1^238.5
 ;;^UTILITY(U,$J,358.3,20978,1,8,0)
 ;;=8^Histiocytic and Mast Cells
 ;;^UTILITY(U,$J,358.3,20978,2)
 ;;=^267778
 ;;^UTILITY(U,$J,358.3,20979,0)
 ;;=238.6^^132^1246^14
 ;;^UTILITY(U,$J,358.3,20979,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20979,1,1,0)
 ;;=1^238.6
 ;;^UTILITY(U,$J,358.3,20979,1,8,0)
 ;;=8^Plasma Cells
 ;;^UTILITY(U,$J,358.3,20979,2)
 ;;=^81973
 ;;^UTILITY(U,$J,358.3,20980,0)
 ;;=238.71^^132^1246^4
 ;;^UTILITY(U,$J,358.3,20980,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20980,1,1,0)
 ;;=1^238.71
 ;;^UTILITY(U,$J,358.3,20980,1,8,0)
 ;;=8^Essential Thrombocythemia
 ;;^UTILITY(U,$J,358.3,20980,2)
 ;;=^334027
 ;;^UTILITY(U,$J,358.3,20981,0)
 ;;=238.72^^132^1246^7
 ;;^UTILITY(U,$J,358.3,20981,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20981,1,1,0)
 ;;=1^238.72
 ;;^UTILITY(U,$J,358.3,20981,1,8,0)
 ;;=8^Low Grade Myelody Synd Lesion
 ;;^UTILITY(U,$J,358.3,20981,2)
 ;;=^334028
 ;;^UTILITY(U,$J,358.3,20982,0)
 ;;=238.73^^132^1246^5
 ;;^UTILITY(U,$J,358.3,20982,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20982,1,1,0)
 ;;=1^238.73
 ;;^UTILITY(U,$J,358.3,20982,1,8,0)
 ;;=8^High Grade Myelody Synd Lesion
 ;;^UTILITY(U,$J,358.3,20982,2)
 ;;=^334029
 ;;^UTILITY(U,$J,358.3,20983,0)
 ;;=238.74^^132^1246^9
 ;;^UTILITY(U,$J,358.3,20983,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20983,1,1,0)
 ;;=1^238.74
 ;;^UTILITY(U,$J,358.3,20983,1,8,0)
 ;;=8^Myelody Synd w/ 5q Deletion
 ;;^UTILITY(U,$J,358.3,20983,2)
 ;;=^334030
 ;;^UTILITY(U,$J,358.3,20984,0)
 ;;=238.75^^132^1246^10
 ;;^UTILITY(U,$J,358.3,20984,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20984,1,1,0)
 ;;=1^238.75
 ;;^UTILITY(U,$J,358.3,20984,1,8,0)
 ;;=8^Myelodysplastic Syndrome
 ;;^UTILITY(U,$J,358.3,20984,2)
 ;;=^334031
 ;;^UTILITY(U,$J,358.3,20985,0)
 ;;=238.76^^132^1246^11
 ;;^UTILITY(U,$J,358.3,20985,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20985,1,1,0)
 ;;=1^238.76
 ;;^UTILITY(U,$J,358.3,20985,1,8,0)
 ;;=8^Myelofibrosis w/Myeloid Metaplasia
 ;;^UTILITY(U,$J,358.3,20985,2)
 ;;=^334032
 ;;^UTILITY(U,$J,358.3,20986,0)
 ;;=238.77^^132^1246^16
 ;;^UTILITY(U,$J,358.3,20986,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20986,1,1,0)
 ;;=1^238.77
 ;;^UTILITY(U,$J,358.3,20986,1,8,0)
 ;;=8^Post Transp Lymphoprolif d/o PTLD
 ;;^UTILITY(U,$J,358.3,20986,2)
 ;;=^336526
 ;;^UTILITY(U,$J,358.3,20987,0)
 ;;=238.79^^132^1246^12
 ;;^UTILITY(U,$J,358.3,20987,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,20987,1,1,0)
 ;;=1^238.79
 ;;^UTILITY(U,$J,358.3,20987,1,8,0)
 ;;=8^Oth Lymph/Hematopoietic Tissue
